EULAR® 2024 Insights

 

Systemic and Connective Tissue Disease
14:03

EULAR® 2024 Insights

EULAR® 2024 Insights- Implications of Newly Established Malignancy Screening Guidelines for Idiopathic Inflammatory Myopathies: A Multicenter, International Evaluation of Clinical and Economic Impact by the Myositis Audit and Research Collaborative Group

FEATURING Jessica Day
  • 147 views
  • July 24, 2024
14:12

EULAR® 2024 Insights

EULAR® 2024 Insights- Implications of Newly Established Malignancy Screening Guidelines for Idiopathic Inflammatory Myopathies: A Multicentre, International Evaluation of Clinical and Economic Impact by the Myositis Audit and Research Collaborative Group

FEATURING Jessica Day
  • 13 views
  • July 24, 2024
09:51

EULAR® 2024 Insights

EULAR® 2024 Insights: Implications of Newly Established Malignancy Screening Guidelines for Idiopathic Inflammatory Myopathies: A Multicentre, International Evaluation of Clinical and Economic Impact by the Myositis Audit and Research Collaborative Group

FEATURING Jessica Day
  • 4 views
  • July 24, 2024
25:12

EULAR® 2024 Insights

Inflammatory Myopathies - Update on Therapies

FEATURING Britta Maurer
  • 375 views
  • July 22, 2024
  • 4
32:04

EULAR® 2024 Insights

Sarcoidosis – (Not Just) Joint, Bone, and Muscles

FEATURING Arthur Yee
  • 501 views
  • July 10, 2024
  • 6
12:45

EULAR® 2024 Insights

EULAR ® Insights - The Most Reliable Tools and Methods and Their Combinations for the Evaluation of the Microcirculation in Systemic Sclerosis

FEATURING Ariane Herrick
  • 82 views
  • June 21, 2024
10:57

EULAR® 2024 Insights

EULAR® 2024 Insights: The Effects of Immunosupressive Therapy on Glandular Involvement in Patients with Primary Sjögren’s Syndrome

FEATURING Guzide Inanc
  • 351 views
  • June 21, 2024
  • 2
05:34

EULAR® 2024 Insights

EULAR® 2024 Insights - Predictive Significance of Biomarkers in Systemic Sclerosis-Associated Interstitial Lung Disease: Insights into Progression, Lung Volume Changes, and Mortality Risk

FEATURING Cristiana Sieiro Santos
  • 108 views
  • June 21, 2024
  • 1
12:52

EULAR® 2024 Insights

EULAR ® Insights: The Most Reliable Tools and Methods and Their Combinations for the Evaluation of the Microcirculation in Systemic Sclerosis

FEATURING Ariane Herrick
  • 12 views
  • June 21, 2024
19:48

EULAR® 2024 Insights

Decoding the Immunopathophysiology of Polymyalgia Rheumatica: Unraveling the Mysteries Within

FEATURING Ernest Choy
  • 103 views
  • June 19, 2024
04:43

EULAR® 2024 Insights

EULAR® 2024 Insights: Characteristics Associated with Long-Term Glucocorticoids Use in Patients with New Onset Polymyalgia Rheumatica

FEATURING Andrea Rubbert-Roth
  • 102 views
  • June 19, 2024